Following stock challenges earlier in the year, the company is now urging vets to encourage farmers to vaccinate their flocks to prevent abortions during lambing.
Roy Geary, regional director for Northern Europe at Ceva Animal Health, said: “While we realise that the temporary delay of Cevac Chlamydia has been inconvenient to our valued sheep farmers we would like to thank all our customers for their patience and support during this challenging time.
"The vaccine supply is now available in the UK for the latter end of the season.
"Farmers tupping later in October should therefore be encouraged to vaccinate their flocks to protect their ewes from this devastating disease.”
www.enzooticabortion.co.uk
There will be 20 presentations from some of the world's leading experts, covering topics such as detection and diagnosis, advances in veterinary oncology, supportive care for the cancer patients, how to build a partnership with pet owners and, of course, feeding the cancer patient.
The presentations will be streamed live and available on demand afterwards, at https://learn.hillsvet.com/en_GB/hills-global-symposium-2023
Dr. Iveta Becvarova, Senior Director of Global Academic & Professional Affairs at Hill's Pet Nutrition said: "This year’s Hill’s Global Symposium will offer the latest advancements and innovations to help veterinary professionals support and counsel their clients, and provide the best care possible to the pets in their care."
Dr Pete Down, Associate Dean for Undergraduate Education in UCLan’s School of Veterinary Medicine, said: “We recognise the multifaceted challenges the profession is facing at the moment, but many of us have spent significant time out in practice and recognise that it can be a fantastic career.
“Additionally, first-opinion vets provide essential services to the pet-owning public, equine, and farming industries.
"Our curriculum focusses on the provision of contextual-care and encourages vet students to see general practice as a fantastic career in and of itself.
"Also, whilst diversity in the profession has traditionally been a challenge, our student recruitment practices support an inclusive approach, recruiting students from a wide variety of backgrounds.”
The practically focused curriculum is ‘hands-on’ from year one and the university says it uses innovative digital technologies from the outset: its students will be among the first in the country to use specialist Anatomage vet tables.
Dr Heather Bacon OBE, Dean of UCLan’s School of Veterinary Medicine, said: “It’s a landmark day for the University as we’ve welcomed our first cohort of veterinary medicine students through the door.
"The demand for places on the first year of our BVMS course was huge and I’m thrilled we’ve been able to enrol so many enthusiastic student vets on to our programme.”
https://www.uclan.ac.uk/undergraduate/courses/veterinary-medicine-surgery-bvms
MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.
The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.
MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.
MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.
This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.
MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.
Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.
Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.
"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.
“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.
"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease.
“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.
"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.”
The studies and articles include a look at the importance of ethics, artificial Intelligence in veterinary practice, retention in the veterinary nursing profession, canine corneal bacterial pathogens, canine appendicular soft tissue sarcomas and mast cell tumours, and autologous mesenchymal stromal cell treatment.
Professor Luisa De Risio, Clinical Research and Excellence Director at Linnaeus, said: “Innovation in clinical research can only happen if we embrace change in society – from new technology to improvements in animal welfare. As well as showcasing the latest research, our new report also brings together experts to consider the opportunities for our profession.”
https://bit.ly/42KFrMK
Tom graduated from the Royal Veterinary College (RVC) in 2017 and joined Synergy Farm Health full-time in 2018, after completing his postgraduate diploma (PGDipVCP) with the RVC.
Nominated by his practice, Tom is described as a fine example of a dedicated caring professional who is passionate about sustainability, has a keen sense of his clients’ needs, and has developed strong working relationships with the farms under his care.
The judging panel found that Tom uses data effectively in herd health planning to highlight areas of improvement, working in partnership with his clients to promote disease prevention and profitability.
Tom’s clients spoke of his knowledge and caring attitude and how much he is valued as part of their team.
Tom said: “It was a privilege to be a part of the awards and to see farmers and businesses acknowledged - farmers don’t always get the recognition they deserve and seeing British dairying showcased was amazing.
"I hope winning is reward for the time and effort colleagues at Synergy put into young vets too, and that I can put it to good use supporting clients and working with other organisations within the dairy industry.
"My aim as a vet has been simply to support clients the best I could, both clinically and emotionally, so to have won made it a fantastic night and one I won’t be forgetting!”
The runner up as Charlie Mays of LLM Vets, who the judging panel praised for making effective changes on farm towards preventive healthcare and using data to assist with health and profitability.
Charlie also lobbies government to support the interests of the farmer and the industry.
Sabrina Jordan from Virbac said: ‘Virbac has been supporting dairy vets with products and services for over 50 years and recognise the commitment of young dairy vets to the profession.
"The standard of nominations into this category was outstanding, and our winner and highly commended nominees are a true credit to the veterinary profession, both are shining lights of the future’.
In response to the question ‘How important is sustainability to you personally?’, 57% of respondents said it was very important making it the most popular choice.
However, in answer to the question: ‘Is your practice team actively working to improve sustainability?’, 20% of respondents said ‘Always/wherever possible’ and 42% said ‘Most of the time’, leaving 38% not actively working to improve sustainability.
IVC says the conclusion to be drawn is that sustainability is a personal priority, but this isn’t always translating to practice and more can be done.
To help with this, the company will shortly Positive Hoofprint, an Equine and Farm specific toolkit to help practices become more sustainable, with resources, checklists and practical advice for prioritising environmentally friendly initiatives.
Mark Tabachnik, UK Head of Equine for IVC Evidensia, said: “It’s clear from our survey that sustainability is still being treated as a secondary concern in practice, and this is something that IVC Evidensia is actively seeking to change.
“With our Positive Hoofprint about to be launched, there has never been a better time to prioritise our sustainability goals and to embed them in our own practices.
“This will give colleagues the tools they need to care for the planet, so we can fundamentally change equine veterinary to be more environmentally conscious for the future.”
Fluboral controls gastro-intestinal nematodes including Ascaridia galli (adult stages), Heterakis gallinarum (adult stages) and Capillaria spp. (adult stages) in chickens and Ascaris suum (adult and L4 intestinal stages) in pigs.
Dechra says Fluboral’s formula allows it to mix in drinking water quickly and easily with five seconds of stirring.
Fluboral has a guaranteed 24-hour stability without sedimentation of the suspension after dilution in drinking water and Dechra says there is no risk of inhomogeneous mixing.
Johnny Wells West, key account manager – pig and poultry at Dechra, said: “Fluboral is a welcome addition to our Solustab range of water-soluble products, providing effortless and efficient parasite control in drinking water to enable farmers and producers to start medication quickly and cost-effectively, as and when needed.”
https://www.dechra.co.uk/products/livestock/prescription/fluboral#Fluboral.
Dr Mark Johnston, CEO of Vetstream said: “The usage data of Vetlexicon has continually shown us how important the client factsheets are to practices helping clients understand the health and welfare of their animals.
"Whilst most of our subscribers are accepting of the Vetlexicon content in English, the preferred language of many pet owners is not necessarily English, and we wanted to help practices with that.
"So a major new dimension to the new Vetlexicon website is to enable the content to be made available in many European and Asian languages so that when you are viewing a client factsheet, you can instantly see that content in Spanish, French or Korean and then print it out on paper and give to the owners for them to share with friends or family on their return to home; or to print it as a PDF and email it to them.
"Practices have told us that this will be so useful for the relationship with their clients, and so it is great to be able to provide that now.”
The company says it has also improved the interface and functionality of the site and made it mobile phone friendly.
www.vetlexicon.com
Brian (pictured right), said: “I am absolutely delighted that Colourful CPD has joined Agilio and I see this as a win-win-win for Colourful CPD, Agilio and the veterinary profession.
"Colourful CPD’s courses complement Agilio’s vast array of existing statutory and mandatory courses which they already distribute within the UK as well as all around the world, thus enabling Colourful CPD to make the move up to the next level, both here and abroad.
I believe veterinary practices, as well as all the roles working within them, will benefit from being able to access a range of new courses and management services from Agilio.”
To mark its expansion into the veterinary sector, Agilio will be launching iTeam, its HR and rota software, together with iLearn, an online training and CPD accredited platform at the London Vet Show in November.
https://www.colourfulcpd.comhttps://agiliosoftware.com
There are four categories of award:
Veterinary practices who feel they have excellence to showcase are invited to submit their nominations via: https://spvs.org.uk/business-excellence-awards, highlighting why they deserve to receive the award against each of the selection criteria.
The deadline for nominations is 5pm on 31st October 2023.
The SPVS Board then will review submissions and shortlist the top 5 nominations in each category.
Shortlisted practices will be contacted by 5pm on the 15th November 2023, and invited to submit a more detailed statement of 750 words or a 90-second video, giving them another opportunity to showcase their accomplishments.
A panel of SPVS members will evaluate the final submissions and vote for a winner in each category.
Category winners will be announced before the end of the year, and will win full day + evening tickets to SPVS Congress 2024 on Thursday 25th January 2024 for three team members, plus overnight accommodation at the Hilton Birmingham Metropole.
The overall winner will be announced at the SPVS Congress 2024 opening ceremony (25th – 27th January 2024).
The day-long CPD course will everything from routine neutering and vaccination, to common presentations like gastrointestinal stasis, renal disease and osteoarthritis, through to more advanced surgical challenges, such as the management of auricular and dental abscesses, liver lobe torsion and small intestinal obstructions.
The day will be divided into lectures given by Marie and Richard, starting with the more common clinical scenarios before extending into the more challenging cases.
Delegates are also invited to prepare any tricky cases to discuss in an open session at the end of the day.
The course costs £300 per delegate, including tea, coffee and buffet lunch plus electronic course notes.
https://evolutionexoticsreferrals.co.uk/cpd-booking-form
They say that dogs which lose sensation following damage to the spinal cord from a slipped disc have a prognosis for recovery of about 50%.
However, there is no reliable way of determining which dog will recover and failing that, owners must wait weeks to months to see if there are any signs of recovery, during which time dogs may need anaesthesia, surgery, and intensive nursing care.
The researchers say that the stiffness of an organ can be a marker of how damaged it is.
So, for the research, a new ultrasound machine equipped with an advanced piece of software (known as ‘shear wave elastography’) – will be used to measure the stiffness of a dog’s spinal cord during surgery.
The dog’s recovery to walking after surgery will then be monitored routinely.
The results will allow researchers to see if a relationship between spinal cord stiffness at time of surgery and recovery exists.
If successful, this would help them provide a more accurate prognosis for dogs with spinal cord injury in the future.
If you have a case suitable for this study, CVS says they will receive a gold standard treatment for spinal cord injury, which will include spinal surgery.
They will also have an ultrasound of the spinal cord performed during surgery, a procedure taking approximately 15 minutes.
Contact referrals@highcroftvet.co.uk or nicolas.granger@bristolvetspecialists.co.uk.
BVS Neurology study from CVS (UK) Ltd on Vimeo.
Asked why the CMA had decided to launch the review, its Senior Director for Consumer Protection told BBC R4's Today programme this morning that: "the costs of many vet services are rising higher than the cost of inflation, and it can be really hard to find out how much it's going to cost you, both for routine treatments or if something goes wrong and you need to find emergency care for your pet."
George added: "There's many other [veterinary] services and costs that people cannot have predicted and they can find themselves unexpectedly facing some really high bills, and when other household bills are going up very steeply at the moment we want to do everything we can to make sure that people can predict how much it is going to cost to see a vet, both for routine stuff but also for things if there's a crisis."
The authority is also looking at whether there is enough transparency over practice ownership.
With the percentage of independent practices falling from 89% in 2013 to 45% by 2021, the authority says people may not be clear if their vet is part of a group which owns other vet practices in their area or that the services which are being sold to them (such as diagnostic tests or treatments at a specialist animal hospital) are provided by that group.
This, it says, could impact pet owners’ choices and reduce the incentives of local vet practices to compete.
The CMA is now asking veterinary professionals, people who supply veterinary products and services and pet owners to take part in the review by completing an online questionnaire: https://www.gov.uk/guidance/how-to-respond-to-the-veterinary-services-market-for-pets-review
In particular, it wants to hear practitioners' experiences of:
The questionnaire will remain open for six weeks.
The CMA will outline the issues it identifies and announce its next steps early in 2024.
The decision was made after Council heard increasing reports that practices have not been keeping records of POM-V parasiticide prescriptions within patient records as has always been required by the VMD.
This created a bit of a problem when the new 'under care' guidance came into force at the start of this month, which requires that veterinary surgeons must perform a physical examination as part of their initial clinical assessment of an animal before prescribing POM-V anti-parasitics.
Failing a record of an existing prescription, that would have meant re-examining large numbers of animals at a time when resources in the profession are already stretched.
RCVS President, Sue Paterson, said: “While it has been both surprising and disappointing to learn of such widespread non-compliance with legislation that has been in place for many years, Council decided to postpone the implementation of this one aspect of our new under care guidance to allow practices additional time to bring their prescribing protocols into line."
The delayed implementation date of 12 January 2024 relates only to the prescription of POM-V anti-parasitics.
The rest of the new under care guidance remains in effect from 1 September 2023
2000 veterinary surgeons and nurses/technicians took part in the study, of which 545 completed all questions.
The biggest equipment barriers to BP measurement were 'cuff frustration' (cuffs pinging off) and difficulties hearing the pulse, which were experienced at least sometimes by 72.2% and 71.6% of participants respectively when using Doppler machines.
When asked about barriers relating to the procedure itself, the most significant issues were a lack of time, not having a colleague available to restrain the cat, and simply forgetting to include BP in the assessment.
Owner-related barriers included difficulties persuading clients to book a separate BP appointment, difficulties persuading clients to bring cats in for a BP check at all, and reticence over the cost.
Sarah Caney, RCVS recognised Specialist in Feline Medicine who lead the study, said: “Feline hypertension is an extremely common condition which affects approximately one in five cats nine years or over4, however there are several challenges that we need to address to enhance the long-term health and welfare of the nation’s cats.
"The good news is that some of the barriers identified in the study can be overcome by taking a ‘practice makes perfect’ attitude towards taking blood pressure, in that the more experience vet professionals have, the easier the procedure will become.
"The study showed many VNs are confident and enthusiastic about blood pressure assessment in cats; this should be encouraged and expanded upon to ensure that as many older cats and those with conditions increasing their risk of hypertension, receive the BP monitoring they deserve.
Eye examinations are helpful in confirming a diagnosis of systemic hypertension, however the study revealed that while 96.5% of respondents had access to a direct ophthalmoscope, 73.1% reported that they felt under-confident in performing and interpreting ocular examinations when identifying hypertensive lesions in cats.
Ceva Animal Health, which funded the study, says that because between 50 and 100% of hypertensive cats have ocular lesions2,3, it is vital that clinicians feel able to identify ocular pathologies associated with high blood pressure.
Sarah added: "VNs and vets should be encouraged to ‘upskill’ their eye examination skills, as this can be extremely helpful in identifying cats with hypertension."
To that end, Ceva has published an online feline ophthalmology course ‘Looking hypertension in the eye’: www.veterinarywebinars.com/community/ceva
The course, which is presented by Dr Ben Blacklock BVSc (Hons), Dipl. ECVO, MRCVS, senior lecturer in veterinary ophthalmology at the University of Edinburgh, is designed to help vets and vet nurses to get the most out of their ocular exams and gain confidence in identifying ocular lesions associated with feline hypertension.
https://easethepressure.co.uk.
References
Dentistry Specialists: Andrew Perry, Jose C. Almansa Ruiz, Rachel Perry, and Bob Partridge, together with veterinary dentists Dr Matthew Oxford FRCVS, Evelyn Barbour-Hill and Susan Thorne join the team of Small Animal Medicine Specialists who are also on hand to answer questions posted by GP vets on VetSurgeon.org
All questions asked on VetSurgeon.org are added to a searchable knowledge base for the benefit of everyone in the profession. So anyone who asks a question is not just doing it for their own benefit, but for everyone.
Questions can be case-related, or broader questions asking what the team thinks about a drug, technique or piece of research.
Anyone who subscribes to the VetSurgeon Digest of questions here, and posts a dentistry question here before 30th September 2023 will have their name put in the hat for a bottle of Moet champagne.
VetSurgeon.org Editor Arlo Guthrie said: “One other thing. Do share this news story with your colleagues in general practice. For them to be able to tap into the minds of some of the leading lights in both dentistry and medicine is a really amazing resource, especially for more recent grads."
Both veterinary professionals and clients can nominate people and practices for one of five awards.
Every professional nominated in the awards will be sent a personalised certificate.
An independent panel of judges from within the veterinary industry will then narrow down the entries to a shortlist of three finalists for each award, who will all be invited to awards ceremony in Manchester on Thursday 21st March 2024.
Bella von Mesterhazy, Sales and Marketing Director at Petplan, said: “Every year we think we’ve seen it all, but then we’re overjoyed by the sheer volume of and enthusiasm behind the latest nominations.
"So for anyone who’s considered nominating before but hasn’t got round to it, this year’s the time to get involved, as we all come together to champion the immense success of the UK’s veterinary industry, whilst celebrating the awards quarter-century anniversary.”
petplan.co.uk/vetawards
Nominations close on 8th January 2024.
The four organisations have written a template letter which anyone can send to any company they see using brachycephalic breeds, such as the Persian, or Scottish Folds, in its marketing materials.
The letter urges companies that use images of cats to work collaboratively with veterinary professionals and pledge to avoid using such breeds in the future.
Dr Nathalie Dowgray, Head of ISFM, said: “Seeing a cute cat in an advertisement can often be a trigger for people to seek out acquiring a cat of that breed without understanding the welfare concerns associated with some pedigree breeds.
"A rise in demand can lead to an increase in breeding practices that result in severe conformational issues and poorer welfare in these breeds.
"We encourage people to download this letter to use when they see breeds of concern being used in advertising, as health is always more important than looks.”
https://icatcare.org/app/uploads/2023/09/ISFM_FECAVA_FVE_UEVPAdvert_Letter.pdf.
AmpliSpec LAB Mastitis uses isothermal amplification technology, which means laboratories can use less expensive equipment.
It also uses the company's lyophilised bead platform, designed to make the test stable and easy to use.
Biotangents says its new test will offer notable cost, speed and accuracy benefits over the traditional culture and PCR testing used by animal health laboratories and veterinary clinics around the world.
CEO Fiona Marshall said: “With 93% sensitivity and 95% specificity, this is a highly sophisticated assay that will help farmers, vets and laboratories to better treat mastitis.
http://www.biotangents.co.uk
Vetlife says the cost of running its Helpline, Health Support, and Financial Support services for the veterinary community is forecast to exceed the £1million mark for the first time in its history, and it is heavily reliant on donations from fundraisers.
If you'd like to support the charity's work and hold a fundraiser, you can do so individually or as part of a team.
First, you're asked to decide on a goal to set yourself or your team.
This could be an overall distance, a total step count, or to be active each day.
The more adventurous can set walking, running, cycling, swimming, kayaking, rock-climbing, or horse-riding goals.
Then create a fundraising page through JustGiving, so you can share the link and spread the word about your event.
Vetlife asks that you tag the charity in any pictures you share on on social media.
Vetlife Communications Officer Eve Ritchie said: “The links between physical activity and mental health are well documented.
"Active October, is the perfect opportunity to get your friends and colleagues together to boost your wellbeing and raise some much-needed funds for our charity.”
You can buy running vests and t-shirts from Vetlife through its website.
If you have any questions about fundraising for Vetlife, email: fundraising@vetlife.org.uk.
www.vetlife.org.uk
The research will specifically focus on Mycoplasma hyopneumoniae (M.hyop), the causative agent of the disease, and aim to progress vaccine development.
Zoetis has stumped up another £300K in kind to support the research.
M.hyop is present in 80% of UK pig herds, which can result in a 16% reduction of growth and a 14% reduction in feed conversion in pigs.
This therefore, is not only a welfare issue for pigs but can significantly increase production costs for farmers.
Piglets are at particular risk of contracting the disease alongside secondary pathogens during lactation.
There are currently no commercial vaccines available that would prevent initial infection, and while M.hyop is susceptible to a variety of antibiotics, their use needs to be reduced to avoid overuse and the occurrence of multi-drug resistant strains.
The priority for the RVC researchers will therefore be developing new vaccines.
The team will also research the optimisation of protocols to eliminate M.hyop from pig herds in an effort to further minimise potential transmission.
Professor Dirk Werling, Professor of Molecular Immunology at the RVC, said: “Infection of Mycoplasma hyopneumoniae is a really debilitating disease in pigs that causes huge economic losses for farmers.
"I am very pleased that we will be able to continue working with a pharmaceutical partner to develop a new vaccine using state-of the-art technologies.”
To raise the funds, CVS put customer and staff collection boxes in its small animal first opinion practices and referral hospitals.
Staff also held a number of fundraising events – including sponsored walks and dog shows, as well as hosting Pet Blood Bank donation days.
The money raised from the partnership will help go towards funding Pet Blood Bank’s work.
Last year the charity sent over 5,000 units of blood to vets across the UK.
Pet Blood Bank provides training for vets and nurses, and donations also help the charity to keep the cost of blood products as low as possible, and provide them free to veterinary charities.
Deputy Chief Executive of CVS Group, Ben Jacklin, said: “Pet Blood Bank is a vital charity doing crucial work within our profession.
"There is no doubt that the level of funds raised is down to the tireless commitment shown by our colleagues up and down the country.
"I’d also like to recognise the role our clients have also made - as without them we would never have reached such a great total.”
Managing Director of Pet Blood Bank, Katrina Wilkinson said: “This generous donation from CVS Group has been incredible to receive.
"We are a small charity so need all the support we can get, and CVS has truly delivered."
CVS has recently announced its next charity partner as Guide Dogs for the Blind.
Skin diseases and palpable masses are a common presentation in guinea pigs brought for veterinary care2.
However, few studies have thus far looked at the prevalence of spontaneously arising diseases in pet guinea pigs.
"Lumpy bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology" retrospectively analysed 619 biopsy samples submitted for histopathology from pet guinea pigs that had presented with externally palpable masses.
The purpose was to determine the most common tissue origins of these masses and the most frequent pathological diagnoses, together with signalment data for the most commonly diagnosed lesions.
Of the 619 samples submitted from 493 animals, 54 (8.7%) had arisen from the mammary glands3 and 15 (2.4%) from the thyroid glands, with the remaining 550 (88.9%) involving the skin and subcutis, muscle (n = 1), salivary glands (n = 4), lips (n = 2), ears (n = 4) and peripheral lymph nodes (n = 23).
Forty-seven (7.6%) of the masses were diagnosed as inflammatory in nature, including dermatitis, panniculitis, lymphadenitis, cheilitis, myositis, sialoadenitis, abscess and chronic inflammation with osseous metaplasia.
Non-neoplastic, non-inflammatory lesions accounted for a further 31 (5.0%), namely cysts, hamartomas, hyperplastic lesions, polyps, ectopic bone formation and salivary gland steatosis.
The remainder of the samples were neoplastic in nature (541; 87.4%), with 99 masses classified as epithelial in origin, 347 as mesenchymal, 23 as round cell, five as melanocytic and eight as unclassified malignant neoplasms.
Of these, mesenchymal neoplasms were further subdivided into benign (288) and malignant (59).
Lipomas were the most common neoplasm diagnosed, accounting for 286 of all samples submitted.
Of all 619 samples included in the study, the eight most commonly diagnosed lesions were lipoma (46.2%), trichofolliculoma (12.3%), sarcoma (of various subtypes: 9.5%), inflammation (all sites 7.6%), lymphoma / leukaemia (3.4%), mammary carcinoma (4%), mammary adenoma (3.2%) and thyroid carcinoma (1.5%).
Overall these eight diagnoses accounted for 87.7% of all submissions from the externally palpable masses from the pet guinea pigs submitted for histopathology.
Melanie said: “Guinea pigs are an increasingly popular household pet.
"Skin diseases, including palpable masses, are a common reason for veterinary presentation. But few studies have been published to date that provide information for clinicians about these conditions.
“This study illustrates the importance of neoplasms of the skin and subcutis in pet guinea pigs, with over 87% of the cases analysed having one of eight diagnoses.
"While most of these neoplasms are benign, a substantial minority are malignant and identifying those lesions is especially important in treatment planning.
"Clinicians dealing with pet guinea pigs should also be aware that some externally palpable masses may arise from the thyroid or mammary glands rather than the skin or subcutis, and that male guinea pigs may also develop mammary lesions.”
The paper has been selected as ‘Editor’s Choice’ by the Journal of Comparative Pathology and will be free to access until September on Lumpy, bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology - ScienceDirect.